A New Japanese Encephalitis Vaccine (Ixiaro)
The FDA has approved a new Japanese encephalitis vaccine (Ixiaro - Intercell/Novartis). It will replace JEVax (Sanofi Pasteur), which has had tolerability and safety problems and is no longer being manufactured....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: A New Japanese Encephalitis Vaccine (Ixiaro)
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1319
Article Code: 1319b
Date: August 24, 2009
Volume: 51
Page: 66
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1319
Article Code: 1319b
Date: August 24, 2009
Volume: 51
Page: 66
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)